Publicaciones en colaboración con investigadores/as de Universidad Europea de Madrid (12)

2020

  1. Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)

    EBioMedicine, Vol. 55

  2. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  3. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2019

  1. Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 4, pp. 725-734

2016

  1. Toward a comprehensive care of HIV patients: finding a strategy to detect depression in a Spanish HIV cohort

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 28, Núm. 7, pp. 834-841

2013

  1. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 25, Núm. 8, pp. 980-989

  2. Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy

    PLoS ONE, Vol. 8, Núm. 7

  3. Should we look for Strongyloides stercoralis in foreign-born HIV-infected persons?

    Journal of Immigrant and Minority Health, Vol. 15, Núm. 4, pp. 796-802

2012

  1. Características clínico-epidemiológicas de los pacientes inmigrantes con infección por el VIH: estudio de 371 casos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 8, pp. 441-451

  2. Chagas disease screening among HIV-positive Latin American immigrants: An emerging problem

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 8, pp. 1991-1997

2009

  1. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

    Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201

2000

  1. Influencia del hospital de día en los requerimientos de ingreso hospitalario de los patientes con sida

    Medicina Clinica, Vol. 114, Núm. 18, pp. 690-693